22,000 patients studied to unlock secrets of deadly heart infection
NCT ID NCT07671118
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This observational study looks back at 22,000 adults in Sweden diagnosed with infective endocarditis, a serious heart valve infection, since 1997. By linking national health records, researchers aim to understand which patients benefit most from valve surgery and what factors affect long-term survival. No new treatments are tested; instead, the goal is to learn from real-world data to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better decide when and how to perform valve surgery for infective endocarditis, potentially improving survival and reducing complications.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. Results may be influenced by factors not fully captured in the registry data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOCARDITIS ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska Institutet
Stockholm, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart infection registry aims to unlock better treatments
- One or two infusions could replace weeks of antibiotics for heart infection
- New study aims to uncover why some heart infections turn deadly
- Virus cocktail fights deadly heart infection in new trial
- Chest ultrasound may replace throat probe for heart infection diagnosis
- Pill power: oral antibiotics may match IVs for serious heart infection